Maeyama K[au] - Search Results

Year	Number of Results
1974	1
1978	1
1980	2
1981	1
1982	5
1983	3
1984	5
1985	3
1986	3
1987	2
1988	7
1989	2
1990	5
1991	6
1992	9
1993	6
1994	7
1995	7
1996	3
1997	2
1998	3
1999	6
2000	4
2001	7
2002	3
2003	4
2004	3
2005	6
2006	8
2007	1
2008	4
2009	4
2010	3
2011	8
2012	6
2013	2
2014	7
2015	3
2016	8
2017	5
2018	9
2019	7
2020	4
2021	2
2022	2

1

Liu S, Maeyama K. Liu S, et al. Among authors: maeyama k. Crit Rev Immunol. 2016;36(2):149-161. doi: 10.1615/CritRevImmunol.2016017062. Crit Rev Immunol. 2016. PMID: 27910765 Review.

2

[Histamine].

Watanabe T, Maeyama K, Wada H. Watanabe T, et al. Among authors: maeyama k. Tanpakushitsu Kakusan Koso. 1984 Nov;29(12 Suppl):1443-58. Tanpakushitsu Kakusan Koso. 1984. PMID: 6098931 Review. Japanese. No abstract available.

3

Nigella sativa as an anti-inflammatory agent in asthma.

Ikhsan M, Hiedayati N, Maeyama K, Nurwidya F. Ikhsan M, et al. Among authors: maeyama k. BMC Res Notes. 2018 Oct 19;11(1):744. doi: 10.1186/s13104-018-3858-8. BMC Res Notes. 2018. PMID: 30340634 Free PMC article.

4

Inhibition of Histamine Release from RBL-2H3 Cells by Zoledronate Did Not Affect Rab27a/Doc2a Interaction.

Sahid MNA, Liu S, Kiyoi T, Maeyama K, Mogi M. Sahid MNA, et al. Among authors: maeyama k. Biol Pharm Bull. 2021;44(12):1902-1906. doi: 10.1248/bpb.b21-00717. Biol Pharm Bull. 2021. PMID: 34853276 Free article.

5

Pharmacology of alpha-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase.

Watanabe T, Yamatodani A, Maeyama K, Wada H. Watanabe T, et al. Among authors: maeyama k. Trends Pharmacol Sci. 1990 Sep;11(9):363-7. doi: 10.1016/0165-6147(90)90181-7. Trends Pharmacol Sci. 1990. PMID: 2238092 Review.

6

[Roles of histamine in the pathogenesis of bronchial asthma and reevaluation of the clinical usefulness of antihistamines].

Yamauchi K, Shikanai T, Nakamura Y, Kobayashi H, Ogasawara M, Maeyama K. Yamauchi K, et al. Among authors: maeyama k. Yakugaku Zasshi. 2011 Feb;131(2):185-91. doi: 10.1248/yakushi.131.185. Yakugaku Zasshi. 2011. PMID: 21297359 Free article. Review. Japanese.

7

Nuclear receptors as targets for drug development: peroxisome proliferator-activated receptor gamma in mast cells: its roles in proliferation and differentiation.

Maeyama K, Emi M, Tachibana M. Maeyama K, et al. J Pharmacol Sci. 2005 Feb;97(2):190-4. doi: 10.1254/jphs.fmj04008x6. Epub 2005 Feb 11. J Pharmacol Sci. 2005. PMID: 15725699 Free article. Review.

8

Mechanism of signal transduction in mast cells and basophils: studies with RBL-2H3 cells.

Beaven MA, Maeyama K, Wolde-Mussie E, Lo TN, Ali H, Cunha-Melo JR. Beaven MA, et al. Among authors: maeyama k. Agents Actions. 1987 Apr;20(3-4):137-45. doi: 10.1007/BF02074652. Agents Actions. 1987. PMID: 3300209 Review. No abstract available.

9

[Role of PPARgamma in inflammatory response related to mast cells].

Maeyama K, Emi M, Chihara K. Maeyama K, et al. Nihon Yakurigaku Zasshi. 2003 Oct;122(4):325-30. doi: 10.1254/fpj.122.325. Nihon Yakurigaku Zasshi. 2003. PMID: 14501168 Review. Japanese.

10

Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism.

Ogasawara M, Yamauchi K, Satoh Y, Yamaji R, Inui K, Jonker JW, Schinkel AH, Maeyama K. Ogasawara M, et al. Among authors: maeyama k. J Pharmacol Sci. 2006 May;101(1):24-30. doi: 10.1254/jphs.fmj06001x6. Epub 2006 Apr 28. J Pharmacol Sci. 2006. PMID: 16648665 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results